Rhodotorula mucilaginosa lymphadenitis in an HIV-infected patient

Int J Infect Dis. 2009 Jan;13(1):e27-9. doi: 10.1016/j.ijid.2008.04.006. Epub 2008 Jul 22.

Abstract

We report a case of lymphadenitis due to Rhodotorula mucilaginosa in a man with well-controlled HIV infection. The diagnosis was established microbiologically by positive lymph tissue cultures, and clinically by responses of lymphadenitis to antifungal therapy. The patient was asymptomatic and was treated with itraconazole 200mg orally once daily as an outpatient. Clinical response was evident within three weeks with improvement of lymphadenopathy on serial computed tomography scans. Lymphadenopathy resolved completely after 8 months of itraconazole therapy and had not recurred 9 months after treatment was stopped.

Publication types

  • Case Reports

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / microbiology*
  • Antifungal Agents / therapeutic use
  • HIV Infections / complications*
  • Humans
  • Itraconazole / therapeutic use
  • Lymph Nodes / microbiology
  • Lymphadenitis / drug therapy
  • Lymphadenitis / microbiology*
  • Male
  • Middle Aged
  • Mycoses / microbiology
  • Rhodotorula / classification
  • Rhodotorula / isolation & purification*

Substances

  • Antifungal Agents
  • Itraconazole